Latest Logos Global Management LP Stock Portfolio
Logos Global Management LP Performance:
2025 Q1: -20.22%YTD: -20.22%2024: 1.99%
Performance for 2025 Q1 is -20.22%, and YTD is -20.22%, and 2024 is 1.99%.
About Logos Global Management LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Logos Global Management LP reported an equity portfolio of $562.5 Millions as of 31 Mar, 2025.
The top stock holdings of Logos Global Management LP are IDYA, RVMD, AKRO. The fund has invested 10.2% of it's portfolio in IDEAYA BIOSCIENCES INC and 10.1% of portfolio in REVOLUTION MEDICINES INC.
The fund managers got completely rid off CYTOKINETICS INC (CYTK), VERA THERAPEUTICS INC (VERA) and MERUS N V (MRUS) stocks. They significantly reduced their stock positions in TREVI THERAPEUTICS INC (TRVI), STRUCTURE THERAPEUTICS INC and OCULAR THERAPEUTIX INC (OCUL). Logos Global Management LP opened new stock positions in NUVALENT INC (NUVL), TEVA PHARMACEUTICAL INDS LTD (TEVA) and XENON PHARMACEUTICALS INC (XENE). The fund showed a lot of confidence in some stocks as they added substantially to GERON CORP (GERN), DISC MEDICINE INC and ANNEXON INC (ANNX).
The top stock holdings of Logos Global Management LP are IDYA, RVMD, AKRO. The fund has invested 10.2% of it's portfolio in IDEAYA BIOSCIENCES INC and 10.1% of portfolio in REVOLUTION MEDICINES INC.
The fund managers got completely rid off CYTOKINETICS INC (CYTK), VERA THERAPEUTICS INC (VERA) and MERUS N V (MRUS) stocks. They significantly reduced their stock positions in TREVI THERAPEUTICS INC (TRVI), STRUCTURE THERAPEUTICS INC and OCULAR THERAPEUTIX INC (OCUL). Logos Global Management LP opened new stock positions in NUVALENT INC (NUVL), TEVA PHARMACEUTICAL INDS LTD (TEVA) and XENON PHARMACEUTICALS INC (XENE). The fund showed a lot of confidence in some stocks as they added substantially to GERON CORP (GERN), DISC MEDICINE INC and ANNEXON INC (ANNX).
Logos Global Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Logos Global Management LP made a return of -20.22% in the last quarter. In trailing 12 months, it's portfolio return was -25.69%.
New Buys
| Ticker | $ Bought |
|---|---|
| nuvalent inc | 35,460,000 |
| teva pharmaceutical inds ltd | 26,129,000 |
| xenon pharmaceuticals inc | 21,807,500 |
| keros therapeutics inc | 20,380,000 |
| 89bio inc | 18,175,000 |
| moonlake immunotherapeutics | 13,674,500 |
| crinetics pharmaceuticals in | 11,739,000 |
| avidity biosciences inc | 10,332,000 |
New stocks bought by Logos Global Management LP
Additions
| Ticker | % Inc. |
|---|---|
| geron corp | 300 |
| disc medicine inc | 97.17 |
| enliven therapeutics inc | 71.43 |
| annexon inc | 56.86 |
| akero therapeutics inc | 50.00 |
| janux therapeutics inc | 32.00 |
| ideaya biosciences inc | 16.67 |
| dyne therapeutics inc | 11.11 |
Additions to existing portfolio by Logos Global Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| trevi therapeutics inc | -66.02 |
| structure therapeutics inc | -39.29 |
| ocular therapeutix inc | -34.29 |
| biontech se | -33.33 |
| soleno therapeutics inc | -28.57 |
| immunovant inc | -8.33 |
Logos Global Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| atyr pharma inc | -3,620,000 |
| travere therapeutics inc | -17,420,000 |
| y-mabs therapeutics inc | -7,830,000 |
| cytokinetics inc | -42,336,000 |
| vera therapeutics inc | -37,003,800 |
| merus n v | -31,537,500 |
| pliant therapeutics inc | -9,877,500 |
| arvinas inc | -13,419,000 |
Logos Global Management LP got rid off the above stocks
Sector Distribution
Logos Global Management LP has about 88.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 88.7 |
| Others | 11.3 |
Market Cap. Distribution
Logos Global Management LP has about 4.6% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 48.7 |
| SMALL-CAP | 29.9 |
| UNALLOCATED | 11.3 |
| LARGE-CAP | 4.6 |
| MICRO-CAP | 4.1 |
| NANO-CAP | 1.3 |
Stocks belong to which Index?
About 72.8% of the stocks held by Logos Global Management LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 72.8 |
| Others | 27.2 |
Logos Global Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Logos Global Management LP
Logos Global Management LP has 39 stocks in it's portfolio. About 62% of the portfolio is in top 10 stocks. JANX proved to be the most loss making stock for the portfolio. AKRO was the most profitable stock for Logos Global Management LP last quarter.
Last Reported on: 15 May, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACRS | aclaris therapeutics inc | 0.60 | 2,222,220 | 3,400,000 | unchanged | 0.00 | ||
| AGLE | spyre therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AKRO | akero therapeutics inc | 8.63 | 1,200,000 | 48,576,000 | added | 50.00 | ||
| ALKS | alkermes plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALLK | allakos inc | 0.12 | 2,900,000 | 660,040 | unchanged | 0.00 | ||
| ANNX | annexon inc | 1.37 | 4,000,000 | 7,720,000 | added | 56.86 | ||
| APLS | apellis pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARVN | arvinas inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATXS | astria therapeutics inc | 0.48 | 500,000 | 2,670,000 | unchanged | 0.00 | ||
| AVTE | aerovate therapeutics inc | 0.62 | 40,000 | 3,514,000 | unchanged | 0.00 | ||
| BPMC | blueprint medicines corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CMPS | compass pathways plc | 1.02 | 2,000,000 | 5,720,000 | new | |||
| CRNX | crinetics pharmaceuticals in | 2.09 | 350,000 | 11,739,000 | new | |||
| CYTK | cytokinetics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DSGN | design therapeutics inc | 2.89 | 4,217,630 | 16,280,000 | unchanged | 0.00 | ||
| DYN | dyne therapeutics inc | 0.93 | 500,000 | 5,230,000 | added | 11.11 | ||
| ERAS | erasca inc | 3.17 | 13,000,000 | 17,810,000 | added | 4.00 | ||
| ETNB | 89bio inc | 3.23 | 2,500,000 | 18,175,000 | new | |||
| EWTX | edgewise therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GERN | geron corp | 2.26 | 8,000,000 | 12,720,000 | added | 300 | ||